Revive Therapeutics Ltd (RVVTF)

[alabama1man]

whether US or Turkey, unless some serious enrollment starts occurring in the next 2 weeks, there's no way they can complete the trial in Q2. They would need to get approx 85 (assuming the 715 number that we last heard is still the current number) by mid-May to get to 800 in Q2 and have the data reviewed (by DSMB?) to get a recommendation whether to unblind / submit. That's looking at the timeline of needing at least 8 days to get the subject through the dosing / evaluation.